Finzati - Logo
ARGX logo

argenx SE

ARGXBiotechnology
$1033.15
-20.31 (-1.93%)
Current price
EarningsLatest report: Dec 31, 2025
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$52.81B
Growth
Cash Flow
1/5
Trend
Volatile
Evidence
Stable or improving margins · 31.1%Positive revenue growth · 62.4%Positive free cash flow · 13.77Manageable debt level · 0.01Healthy liquidity · 5.23
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Dec 31, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$1,033.15
Change-1.93%
Market Cap$52.81B
52W Range510.06 - 934.62
Beta-0.03
Gross Margin89.15%
Oper. Margin25.39%
Profit Margin31.11%
Debt/Eq0.01
Current Ratio5.23
Quick Ratio4.87
Target$1,136.83

Investment DNA

How strong this company looks for long-term investors

74
out of 100
Business Quality
Margins, moat, returns
90/100
Financial Strength
Debt, cash, stability
95/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
25/100
Why this score
Stable or improving margins · 31.1%Positive revenue growth · 62.4%Positive free cash flow · 13.77Manageable debt level · 0.01Healthy liquidity · 5.23Expensive earnings multiple · 39.9

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-06-24
Low
$940.00
Mean
$1136.83
Median
$1152.50
High
$1291.00

Company Overview

IPO: 5/18/2017
Industry: Biotechnology
P/B i: 7.04
Debt / Equity i: 0.01
Operating Margin: 25.39%
Net Margin: 31.11%
ROE i: -
ROIC: -

Financial Health

Score19 / 20
Debt / Equity: 0.01
Current Ratio: 5.23
Quick Ratio: 4.87
Status: Strong
🧾

No insider activity

No recent insider transactions available.